Hemosure® is pleased to announce that it will attend the American Association of Clinical Chemistry (AACC) annual meeting, July 26 -30, 2015 in Atlanta, GA, Booth 4019.
Hemosure Immunochemical FOB Test (FIT) provides better patient care over the old guaiac (FOBT) method that the 2009 ACG Guidelines recommend be abandoned as a method for Colorectal Cancer (CRC) screening. With the new 2009 ACG Guidelines in mind, now is the time to change the outdated guaiac method you are using and begin experiencing the advantages of iFOBT (FIT) technology that offers clear accurate results, higher sensitivity and specify. Hemosure® can help increase your revenue with the higher reimbursement by Medicare but more importantly Hemosure® iFOBT gives you the opportunity to increase patient compliance through a higher rate of analytical accuracy.
Please give us a call if you have any questions or would like to order a FREE Evaluation Kit for your Laboratory and/or FREE CRC Awareness Kits for your facility at toll free 888-HEMOSURE (436-6787) or you can request more information at www.hemosure.com.